Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on April 15, 2025
Kansas City University College of Osteopathic Medicine launches behavioral health and leadership tracks
EIN Presswire
·
April 15, 2025
KANSAS CITY, MO, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- In an ever-evolving health care landscape, Kansas City University College of Osteopathic Medicine is leading the way with two innovative tracks in behavioral health and leadership. …
Jacqueline Hess Joins Immunophotonics Board of Directors
EIN Presswire
·
April 15, 2025
ST. LOUIS, MO, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on immuno-oncology, is pleased to announce the appointment of Jacqueline Hess to its Board of Directors. With over 30 years …
St. Louis Plastic Surgeon Highlights What to Look for in Breast Augmentation Doctor
EIN Presswire
·
April 15, 2025
Dr. Jeffrey Copeland discusses qualifications and criteria patients should research when selecting a doctor to perform their breast augmentation surgery. ST. PETERS, MO, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Breast augmentation surgery is …
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
GlobeNewswire
·
April 15, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …
Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis
GlobeNewswire
·
April 15, 2025
Photo Courtesy of Diet By Tam BEIRUT, Lebanon, April 15, 2025 (GLOBE NEWSWIRE) -- Diet by Tam, a health and wellness company based in Beirut, has announced the expansion of its functional supplement range with the introduction of five new products. The …
Theratechnologies Provides Update on Sale Process
GlobeNewswire
·
April 15, 2025
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current …
Theratechnologies fait le point sur le processus de vente
GlobeNewswire
·
April 15, 2025
MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …
Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care
GlobeNewswire
·
April 15, 2025
CEDAR PARK, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Ascension Seton is deepening its commitment to patient-centered care in Central Texas by acquiring full ownership of Cedar Park Medical Center. This transition marks a significant step in Ascension …
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 15, 2025
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
GlobeNewswire
·
April 15, 2025
Reports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific …
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
GlobeNewswire
·
April 15, 2025
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
GlobeNewswire
·
April 15, 2025
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …
Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery
GlobeNewswire
·
April 15, 2025
Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
GlobeNewswire
·
April 15, 2025
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
GlobeNewswire
·
April 15, 2025
The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expected to add to RadNet’s wholly owned subsidiary, DeepHealth, …
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …